Langerhans-cell histiocytosis
Langerhans-Cell Histiocytosis A spectrum of diseases formerly known as histiocytosis X and
now called Langerhans-cell histiocytosis is characterized by ERK pathway activation
(including BRAF V600E mutations) and diverse clinical manifestations involving bone, skin,
lung, and pituitary.
now called Langerhans-cell histiocytosis is characterized by ERK pathway activation
(including BRAF V600E mutations) and diverse clinical manifestations involving bone, skin,
lung, and pituitary.
Langerhans-Cell Histiocytosis
A spectrum of diseases formerly known as histiocytosis X and now called Langerhans-cell histiocytosis is characterized by ERK pathway activation (including BRAF V600E mutations) and diverse clinical manifestations involving bone, skin, lung, and pituitary.
The New England Journal Of Medicine